Author
Listed:
- Aixue Zhang
(Fudan University
National Health Commission of the People’s Republic of China (Fudan University))
- Jing Li
(Fudan University)
- Zhuxin Mao
(University of Antwerp)
- Zitong Wang
(Fudan University)
- Jing Wu
(Tianjin University)
- Nan Luo
(National University of Singapore)
- Peng Liu
(Fudan University)
- Pei Wang
(Fudan University
National Health Commission of the People’s Republic of China (Fudan University))
Abstract
Aim To assess and compare the measurement properties of EQ-5D-5L and SF-6Dv2 among lymphoma patients in China. Methods A face-to-face survey of Chinese lymphoma patients was conducted at baseline (all types) and follow-up (diffuse large B-cell). EQ-5D-5L and SF-6Dv2 health utility scores (HUSs) were calculated using the respective Chinese value sets. Ceiling effect was assessed by calculating the percentage of respondents reporting the optimal health state. Convergent validity of EQ-5D-5L and SF-6Dv2 was assessed using the Spearman rank correlation coefficient (r) with QLQ-C30 as a calibration standard. Known-groups validity of the two HUSs was evaluated by comparing their scores of patients with different conditions; and their sensitivity was further assessed in the known-groups using relative efficiency (RE). Test–retest reliability and responsiveness was tested using ICC and standardized response mean (SRM), respectively. Results Altogether 200 patients were enrolled at baseline and 78 were followed up. No ceiling effect was found for SF-6Dv2 compared to 24.5% for EQ-5D-5L. Correlation between the two HUSs and with QLQ-C30 score was strong (r > 0.5). Each dimension of EQ-5D-5L and SF-6Dv2 had moderate or greater correlations with similar dimensions of QLQ-C30 (r > 0.35). Both EQ-5D-5L and SF-6Dv2 could only a minority known-groups, and the latter may have better sensitivity. EQ-5D-5L had better test–retest reliability (ICC = 0.939); while both of them were responsive to patients with worsened and improved clinical status. Conclusions EQ-5D-5L and SF-6Dv2 were found to have good convergent validity and responsiveness, while EQ-5D-5L had better test–retest reliability and higher ceiling effect. Not enough evidence indicates which of the two measures has better known-group validity and sensitivity.
Suggested Citation
Aixue Zhang & Jing Li & Zhuxin Mao & Zitong Wang & Jing Wu & Nan Luo & Peng Liu & Pei Wang, 2024.
"Psychometric performance of EQ-5D-5L and SF-6Dv2 in patients with lymphoma in China,"
The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(9), pages 1471-1484, December.
Handle:
RePEc:spr:eujhec:v:25:y:2024:i:9:d:10.1007_s10198-024-01672-4
DOI: 10.1007/s10198-024-01672-4
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:eujhec:v:25:y:2024:i:9:d:10.1007_s10198-024-01672-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.